Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving virus or bacteriophage
Reexamination Certificate
2007-10-30
2007-10-30
Campell, Bruce R. (Department: 1648)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving virus or bacteriophage
C435S006120
Reexamination Certificate
active
11006313
ABSTRACT:
The present invention provides a replication competent hepatitis C virus that includes a heterologous polynucleotide. The invention also includes methods for modifying a hepatitis C virus polynucleotide, selecting a replication competent hepatitis C virus polynucleotide, detecting a replication competent hepatitis C virus polynucleotide, and identifying a compound that inhibits replication of a hepatitis C virus polynucleotide.
REFERENCES:
patent: 5766906 (1998-06-01), Lemon et al.
patent: 5846767 (1998-12-01), Halpin et al.
patent: 5874565 (1999-02-01), Rice et al.
patent: 5912167 (1999-06-01), Palmenberg et al.
patent: 6127116 (2000-10-01), Rice et al.
patent: 6392028 (2002-05-01), Rice, III et al.
patent: 6689559 (2004-02-01), Wimmer et al.
patent: 6930095 (2005-08-01), Bichko
patent: 6943246 (2005-09-01), Rice et al.
patent: 7049428 (2006-05-01), Rice, III et al.
patent: 2002/0155582 (2002-10-01), Lemon et al.
patent: 2003/0125541 (2003-07-01), Lemon et al.
patent: WO 00/14263 (2000-03-01), None
patent: WO 02/059321 (2002-08-01), None
Zhong et al. PNAS, 2005, vol. 102, No. 26, pp. 9294-9299.
Graham et al. Antiviral Research 2006, vol. 69, pp. 24-30.
Kanda et al. J. Virol. 2006, vol. 80, No. 9, p. 4633-4639.
Heller et al. PNAS, 2005, vol. 102, No. 7, pp. 2579-2583.
Cai et al. J. Virol. 2005, vol. 79, No. 22, pp. 13963-13973.
Murry et al. J. Virol. 2003, vol. 77, No. 5, pp. 2928-2935.
Bartenschlager et al. Journal of General Virology 2000, vol. 81, pp. 1631-1648.
Bukh et al., “Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzees,”PNAS, Oct. 29, 2002;99(22):14416-14421.
Ausubel et al., eds.,Current Protocols in Molecular Biology, vol. 1-4, John Wiley & Sons, U.S.; title page, publication page and table of contents only, 12 pgs. (1994).
Bartenschlager et al., “Replication of hepatitis C virus,”Journal of General Virology, 2000,81: 1631-48.
Beard et al., “An Infectious Molecular Clone of a Japanese Genotype Ib Hepatitis C Virus,”Hepatology, Jul. 1999;30(1):316-24.
Berger et al., “Secreted Placental Alkaline Phosphatase: A Powerful New Quantitative Indicator of Gene Expression in Eukaryotic Cells,”Gene. Jun. 15, 1988;66(1):1-10.
Bieniasz et al., “Highly Divergent Lentiviral Tat Proteins Activate Viral Gene Expression by a Common Mechanism,”Mol Cell Biol. Jul. 1999;19(7):4592-9.
“BLAST,” National Institutes of Health, Bethesda, MD [online]. Retrieved from Internet on Apr. 17, 2001. <URL:http://www.ncbi.nlm.nih.gov/gorf/b12.html>, 2 pgs.
Blight et al., “Efficient Initiation of HCV RNA Replication in Cell Culture,”Science, Dec. 8, 2000;290(5498):1972-5.
Bukh et al., “Sequence analysis of the 5′ noncoding region of hepatitis C virus,”Proc. Nat. Acad. Sci. USA, 1992;89: 4942-46.
Cullen,“Trans-activation of Human Immunodeficiency Virus Occurs via a Bimodal Mechanism,”Cell. Sep. 26, 1986;46(7):973-82.
Cullen, Bryan R., “HIV-1 Auxiliary Proteins: Making Connections in a Dying Cell,”Cell, 1998;93: 685-92.
Forns et al., “Hepatitis C Virus Lacking the Hypervariable Region 1 of the Second Envelope Protein Is Infectious and Causes Acute Resolving or Persistent Infection in Chimpanzees,”Proc Natl Acad Sci U S A. Nov. 21, 2000;97(24):13318-23.
Frese et al., “Interferon-α inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway,”J. Gen. Virol., Apr. 2001;82 (pt.4): 723-33.
Fujisawa et al., “The Indirect Association of Human T-cell Leukemia VirustaxProtein with DNA Results in Transcriptional Activation,”J Virol. Aug. 1991;65(8):4525-8.
Guo et al., “Identification of a Novel RNA Species in Cell Lines Expressing HCV Subgenomic Replicons,” Abstract P045, 7th International Meeting on Hepatitis C Virus and Related Viruses (Molecular Virology and Pathogenesis), The Marriott Resort Hotel, Gold Coast, Queensland, Australia, Dec. 3-7, 2000.
Guo et al., “Effect of Alpha Interferon on the Hepatitis C Virus Replicon,”J. Virol., 2001; 75: 8516-23.
Hadzopoulou-Cladaras et al., “Therev(trs/art) Protein of Human Immunodeficieny Virus Type 1 Affects Viral mRNA and Protein Expression via acis-acting Sequence in theenvRegion,”J Virol. Mar. 1989;63(3):1265-74.
Harlow et al.,Antibodies: A Laboratory Manual, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY; title page, publisher's page, and table of contents, 9 pages (1988).
Hayashi et al., “Molecular cloning and heterogeneity of the human hepatitis C virus (HCV) genome,”J. Hepatol., 1993;17: S94-S107.
Honda et al., “Stability of a stem-loop involving the initiator AUG controls the efficiency of internal initiation of translation of hepatitis C virus RNA,”RNA, 1996;2: 955-68.
Ikeda et al., “Selectable Subgenomic and Genome-Length Dicistronic RNAs Derived from an Infectious Molecular Clone of the HCV-N Strain of Hepatitis C Virus Replicate Efficiently in Cultured Huh7 Cells,”J. Virol., Mar. 2002;76(6): 2997-3006.
Kim et al., “Domains I and II in the 5′ Nontranslated Region of the HCV Genome Are Required for RNA Replication,”Biochem Biophys Res Comm., 2002;290: 105-112.
Kolykhalov et al., “Identification of a Highly Conserved Sequenced Element at the 3′ Terminus of Hepatitis C Virus Genome RNA,”J Virol. Jun. 1996;70(6):3363-71.
Kolykhalov et al., “Hepatitis C Virus-encoded Enzymatic Activities and Conserved RNA Elements in the 3′ Nontranslated Region Are Essential for Virus Replication In Vivo,”J Virol. Feb. 2000;74(4):2046-51.
Krieger et al., “Enhancement of Hepatitis C Virus RNA Replication by Cell Culture-Adaptive Mutations,”J. Virol., 2001;75: 4614-24.
Lai et al., “Generation and Characterization of a Hepatitis C Virus NS3 Protease-dependent Bovine Viral Diarrhea Virus,”J Virol. Jul. 2000;74(14):6339-47.
Lanford et al., “Lack of Detection of Negative-strand Hepatitis C Virus RNA in Peripheral Blood Mononuclear Cells and Other Extrahepatic Tissues by the Highly Strand-specific rTth Reverse Transcriptase PCR,”J Virol. Dec. 1995;69(12):8079-83.
Lemon, “Selection of Cell Culture-adapted Hepatitis C RNA,” Grant Abstract for Grant No. 2U19AI40035-050001 [online]. National Institute of Allergy and Infectious Diseases, National Institutes of Health; project dates Aug. 1, 1996 to Jul. 31, 2005. Retrieved from the Internet on Apr. 17, 2001; URL: <http://commons.cit.nih.gov/crisp/crisp—lib.getdoc?textkey=6340699&p—query=&ticket=1907498&p—audit—session—id=4197699&p—keywords=>, 2 pages.
Lemon, “The Southeastern Cooperative Hepatitis C Research Group,” Grant Abstract for Grant No. 2U19AI40035-05 [online]. National Institute of Allergy and Infectious Diseases, National Institutes of Health; project dates Aug. 1, 1996 to Jul. 31, 2005. Retrieved from the Internet on Apr. 17, 2001; URL: <http://commons.cit.nih.gov/crisp/crisp—lib.getdoc?textkey=6199426&p—query=&ticket=1907498&p—audit—session—id=4197699&p—keywords=>, 2 pages.
Li et al., “Cellular response to conditional expression of Hepatitis C virus core protein in Huh7 cultured human hepatoma cells,”Hepatology, May 2002;35(5):1237-1246.
Lohmann et al. “Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line,”Science. Jul. 2, 1999;285(5424):110-3.
Lohmann et al., “Adaptation of Selectable HCV Replicon to a Human Hepatoma Cell Line,” Abstract P038, 7th International Meeting on Hepatitis C Virus and Related Viruses (Molecular Virology and Pathogenesis), The Marriott Resort Hotel, Gold Coast, Queensland, Australia, Dec. 3-7, 2000.
Lohmann et al. “Mutations in Hepatitis C Virus RNAs Conferring Ce
Lemon Stanley M.
Yin MinKyung
Board of Regents , The University of Texas System
Li Bao Qun
Mueting Raasch & Gebhardt, P.A.
LandOfFree
Replication competent hepatitis C virus and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Replication competent hepatitis C virus and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Replication competent hepatitis C virus and methods of use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3836481